Shree Ganesh Bio-Tech (India) Limited (SHREEGANES.BO)
INR 1.05
(0.0%)
INR 1.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 101.57 Million | 105.39 Million | 35.66 Million | 23.64 Million | -10.08 Million | -4.99 Million |
| Net Income | 6.2 Million | 27.14 Million | 34.99 Million | 4.28 Million | 2.35 Million | 17.89 Million |
| Depreciation & Amortization | 5000.00 | 5000.00 | 5000.00 | 6164.00 | 10.67 Thousand | 10.67 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 99.77 Million | 85 Million | 10.4 Million | 20.46 Million | -12.45 Million | -22.9 Million |
| Other non-cash items | -103.38 Million | -6.75 Million | -9.73 Million | -1.11 Million | 12.37 Million | 22.89 Million |
| Investing Cash Flow | -102.09 Million | -100.94 Million | -33.65 Million | -23.58 Million | 9.86 Million | -320.69 Million |
| Investments in PPE | - | - | - | - | - | -56 Thousand |
| Acquisitions | - | 32.19 Million | -1.59 Million | -30.6 Million | - | - |
| Investment purchases | - | - | -1.59 Million | -30.6 Million | - | - |
| Sales/Maturities of investments | - | 32.19 Million | - | - | - | - |
| Other Investing Activities | -102.09 Million | -165.33 Million | -30.46 Million | 37.62 Million | 9.86 Million | -320.63 Million |
| Financing Cash Flow | - | - | -1.9 Million | - | - | 325.8 Million |
| Debt repayment | - | - | -1.9 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 325.8 Million |
| Other Financing Activities | - | - | -20.00 | - | - | 325.8 Million |
| Accounts receivables | 160.25 Million | 245.62 Million | -155.51 Million | -75.47 Million | -16.3 Million | -56.42 Million |
| Accounts payables | -61.27 Million | -158.18 Million | 157.8 Million | 94.75 Million | 3.95 Million | 33.55 Million |
| Inventory | - | - | -277.00 | -1.00 | 180.00 | - |
| Other working capital | 796 Thousand | -2.42 Million | 8.1 Million | 1.19 Million | -100.18 Thousand | -25.58 Thousand |
| Cash at beginning of period | 4.8 Million | 352 Thousand | 242 Thousand | 178.57 Thousand | 396.48 Thousand | 280.58 Thousand |
| Cash at end of period | 4.28 Million | 4.8 Million | 352 Thousand | 241.85 Thousand | 178.57 Thousand | 396.48 Thousand |
| Capital Expenditure | - | - | - | - | - | -56 Thousand |
| Effect of forex changes on cash | - | - | -1000.00 | - | - | - |
| Net cash flow / Change in cash | -521 Thousand | 4.44 Million | 110 Thousand | 63.28 Thousand | -217.91 Thousand | 115.9 Thousand |
| Free Cash Flow | 101.57 Million | 105.39 Million | 35.66 Million | 23.64 Million | -10.08 Million | -5.04 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.43 Million | 6.2 Million | 869 Thousand | 751 Thousand | 1.49 Million | -5.79 Million |
| Depreciation & Amortization | - | 5000.00 | - | - | - | 6000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 99.77 Million | - | - | - | - |
| Other non-cash items | -5.43 Million | -103.38 Million | -869 Thousand | -751 Thousand | -1.49 Million | 5.79 Million |
| Investing Cash Flow | - | -102.09 Million | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -102.09 Million | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | 160.25 Million | - | - | - | - |
| Accounts payables | - | -61.27 Million | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 796 Thousand | - | - | - | - |
| Cash at beginning of period | - | 4.8 Million | 685 Thousand | -66 Thousand | 4.8 Million | 3.83 Million |
| Cash at end of period | - | 4.28 Million | 685 Thousand | 685 Thousand | 1.49 Million | 4.8 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -521 Thousand | - | 751 Thousand | -3.3 Million | 964 Thousand |
| Free Cash Flow | - | 101.57 Million | - | 751 Thousand | 1.49 Million | 964 Thousand |
PLYZ
WDP
NUVB-WT
000526
SSAB-A
BERI